Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Inogen Inc (INGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,824,819
  • Shares Outstanding, K 21,350
  • Annual Sales, $ 249,440 K
  • Annual Income, $ 21,000 K
  • 36-Month Beta 1.56
  • Price/Sales 11.81
  • Price/Cash Flow 70.44
  • Price/Book 10.11

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate 0.27
  • Number of Estimates 6
  • High Estimate 0.35
  • Low Estimate 0.22
  • Prior Year 0.31
  • Growth Rate Est. (year over year) -12.90%

Price Performance

See More
Period Period Low Period High Performance
1-Month
127.25 +9.24%
on 11/15/18
213.93 -35.02%
on 10/18/18
-62.68 (-31.08%)
since 10/15/18
3-Month
127.25 +9.24%
on 11/15/18
287.79 -51.70%
on 09/13/18
-89.65 (-39.21%)
since 08/15/18
52-Week
112.78 +23.26%
on 01/10/18
287.79 -51.70%
on 09/13/18
+20.70 (+17.50%)
since 11/15/17

Most Recent Stories

More News
Inogen Announces Participation in the Piper Jaffray 30th Annual Healthcare Conference

Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company's management...

INGN : 139.01 (+5.06%)
Inogen Inc Down 48.1% Since SmarTrend Downtrend Call (INGN)

SmarTrend identified a Downtrend for Inogen Inc (NASDAQ:INGN) on September 24th, 2018 at $252.64. In approximately 2 months, Inogen Inc has returned 48.10% as of today's recent price of $131.13.

INGN : 139.01 (+5.06%)
After Yesterday's Decline of 3.98%, Inogen Inc Offers Investors Better Value

Inogen Inc (NASDAQ:INGN) traded in a range yesterday that spanned from a low of $131.72 to a high of $139.26. Yesterday, the shares fell 4.0%, which took the trading range below the 3-day low of $135.69...

INGN : 139.01 (+5.06%)
After Yesterday's Decline of 1.57%, Inogen Inc Offers Investors Better Value

Inogen Inc (NASDAQ:INGN) traded in a range yesterday that spanned from a low of $140.70 to a high of $148.00. Yesterday, the shares fell 1.6%, which took the trading range below the 3-day low of $143.63...

INGN : 139.01 (+5.06%)
Inogen (INGN) Q3 Earnings Beat, 2018 Revenue Guidance Up

Inogen (INGN) gains from solid direct-to-consumer revenues in Q3; 2018 view up.

MMSI : 59.10 (+2.25%)
SYK : 168.72 (+1.64%)
ISRG : 513.64 (+3.01%)
INGN : 139.01 (+5.06%)
Omnicell (OMCL) Hits Fresh High: Is There Still Room to Run?

Omnicell (OMCL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

OMCL : 70.95 (+2.54%)
CPSI : 25.56 (+0.71%)
ICUI : 243.96 (+8.67%)
INGN : 139.01 (+5.06%)
Noteworthy Wednesday Option Activity: INGN, PLNT, WWW

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Inogen, Inc , where a total volume of 1,936 contracts has been traded thus far today,...

INGN : 139.01 (+5.06%)
Is Inogen (INGN) Outperforming Other Medical Stocks This Year?

Is (INGN) Outperforming Other Medical Stocks This Year?

INGN : 139.01 (+5.06%)
Inogen (INGN) Surpasses Q3 Earnings and Revenue Estimates

Inogen (INGN) delivered earnings and revenue surprises of 40.38% and 4.62%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

INGN : 139.01 (+5.06%)
Inogen: 3Q Earnings Snapshot

GOLETA, Calif. (AP) _ Inogen Inc. (INGN) on Tuesday reported third-quarter profit of $16.4 million.

INGN : 139.01 (+5.06%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade INGN with:

Business Summary

Inogen, Inc. is a medical technology company. It offers oxygen concentrator, cart, carry bags, backpacks, external battery chargers and universal power supply for obstructive pulmonary disease patients. The Company's products include Inogen One G3 and Inogen One G2. It sells its products in the United...

See More

Key Turning Points

2nd Resistance Point 147.78
1st Resistance Point 143.40
Last Price 139.01
1st Support Level 130.94
2nd Support Level 122.86

See More

52-Week High 287.79
Fibonacci 61.8% 220.94
Fibonacci 50% 200.29
Fibonacci 38.2% 179.63
Last Price 139.01
52-Week Low 112.78

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar